Clinical Trials
A Multi-Drug Trial On Cancer Precision Medicine Has Begun
A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK has begun for patients with rare cancers who need additional treatment options. The DETERMINE study is one of the only platform trials using precision...
Clinical Trials
Digital Trials Evolving Due To Single, Connected Foundation
Clinical trials have expanded from 2,119 in 2000 to over 409,000 in 2022 (and counting). Not only has the number of trials increased, but so has the volume of data.
Phase III clinical trials generate 3.6 million data points on...
Clinical Trials
NICE Offers Historical Clinical Funding To Kidney Cancer UK
Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and Care Excellence (NICE) to create the first-ever clinical guidelines for the disease.
The organisation conducted an...
Clinical Trials
Edible Sensor Monitors HIV Patients Antiretroviral Doses
A new ingestible sensor system that was put to the test in an interventional clinical trial gave HIV patients real-time antiretroviral dosage information, helping them to better manage their infection.
The Proteus Digital Health Feedback (PDHF) information technology system kept...
Clinical Trials
A New Initiative To Assess Clinical Trials Carbon Footprint
The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical trials, has been launched by The Pistoia Alliance, a non-profit organisation that promotes R&D collaboration...
Clinical Trials
Seven Pharma CEOs Team Together To Accomplish Emission Aims
Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to meet short-term emission reduction goals and hasten the implementation of net zero health systems.
The Sustainable Markets Initiative (SMI) Health...
Clinical Trials
Next ASH To Focus Bispecific Cancer Drugs And Gene Therapy
The 64th annual meeting of the American Society of Hematology, a prestigious venue for some of their field's most significant research, will be held in New Orleans in December, and blood disease specialists and medical professionals will fly there.
With...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read